Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
18
-
Total shares
-
1.06M
-
Shares change
-
+50.1K
-
Total reported value, excl. options
-
$1.3M
-
Value change
-
+$57.9K
-
Number of buys
-
11
-
Number of sells
-
-3
-
Price
-
$1.23
Significant Holders of HCW Biologics Inc. - COM (HCWB) as of Q4 2023
18 filings reported holding HCWB - HCW Biologics Inc. - COM as of Q4 2023.
HCW Biologics Inc. - COM (HCWB) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.06M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (205K shares), HighTower Advisors, LLC (180K shares), Avantax Planning Partners, Inc. (180K shares), GEODE CAPITAL MANAGEMENT, LLC (134K shares), Cresset Asset Management, LLC (132K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (84.7K shares), BlackRock Inc. (47.2K shares), AE Wealth Management LLC (30K shares), TWO SIGMA INVESTMENTS, LP (22.6K shares), and STATE STREET CORP (21.4K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.